A MEMORANDUM of Understanding (MoU) for medicinal cannabis research between an Australian and Japanese organisation was signed this week.
Medicinal cannabis company Cannatrek signed an MoU with Mie University in Tsu, Japan, with the aim of forging an open collaboration focused on accelerating medical research into the use of cannabis.
The MoU followed the Japanese Govt's recent change towards the use of cannabis with the Lower House passing the bill to legalise the use of medical products made from cannabis in mid-Nov last year.
Under the MoU, the framework for cooperation encompasses areas including agronomic research, training resources for clinicians, pharmaceutical supply chain, e-healthcare, navigating regulation and compliance, and connecting experts in the field.
Cannatrek CEO Tommy Huppert said with quality products manufactured in its Shepparton facility, export opportunities were enhanced.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jan 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jan 24
